Mainstay Medical full year 2015 preliminary results and business update
on 16/02/2016 14:15
mainstay
Additional data confirm positive results for Clinical Trial of ReActiv8®
on 04/12/2015 10:24
Additional data confirm clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more
Read more
Mainstay Medical Applies for CE Mark for ReActiv8®
on 02/11/2015 11:38
A key step towards European commercialisation of innovative treatment of chronic low back pain
Read more
Read more
Positive Results for Mainstay Medical’s Clinical Trial of ReActiv8®
on 31/08/2015 11:34
Clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options.
Read more
Read more
